John Ivison: The math of saving lives — Canada’s drug battle leaves patients caught in the middle
Article content continued We feel that everyone is blaming someone else and patients are caught in the middle Vertex has done spectacularly well from Trikafta this year, reporting sales of US$ 918 million in second quarter of this year, from zero last year. That helped the company’s net income to soar 213 per cent year… Read More »
